Table 3 Clinical outcomes of cardiac surgical patients who were randomised to receive succinylated gelatin (4%) (GEL) or compound sodium lactate (CSL) as fluid resuscitation therapy after cardiac surgery

KDIGO stage*, n (%)

0.73

 Stage I

4 (20)

7 (35)

–

 Stage II

1 (5)

1 (5)

–

 Stage III

0

0

–

28-day RRT-free days

28 (28–28)

28 (28–28)

N/A

Chest drain output (mL)

485 (344–687)

335 (268–428)

0.05

Received blood products, n (%)

 Packed red blood cells

5 (25)

0 (0)

0.05

 Cryoprecipitate

1 (5)

0 (0)

N/A

 Platelet concentrate

1 (5)

0 (0)

N/A

Received albumin, n (%)

2 (10)

2 (10)

N/A

Return to theatre, n (%)

3 (15)

0 (0)

0.23

Ventilation time (hours)

17 (11–30)

11 (10–15)

0.06

Fluid balance (mL)

1751 (872–3022)

1261 (688–2214)

0.27

28-day ICU-free-days

26 (24–27)

26 (24–27)

0.60

60-day mortality, n (%)

0 (0)

0 (0)

N/A